Pollard B J
Department of Anaesthesia, Manchester Royal Infirmary, UK.
Acta Anaesthesiol Scand Suppl. 1995;106:58-61. doi: 10.1111/j.1399-6576.1995.tb04312.x.
For total intravenous anaesthesia (TIVA), all drugs that are required as part of the anaesthetic method are administered intravenously. This is usually taken to imply the use of intravenous infusions. It is normal practice to administer muscle relaxants intravenously, although other routes have been used. A muscle relaxant is required firstly to secure paralysis and secondly to maintain paralysis. The rate of onset of all the nondepolarizing neuromuscular blocking agents which are routinely available at present is similar; it takes about 3-6 min for a normal clinical dose to reach maximum effect. Maintenance of an adequate level of block is necessary, and it is usually helpful to the surgeon for the level of block to be relatively constant. The choice of drug is important. It should cause negligible side-effects. For administration by infusion, an agent with an intermediate (e.g., atracurium) or short (e.g., mivacurium) duration of action is essential to ensure a rapid recovery of effect on termination of the infusion. The routine use of neuromuscular monitoring is recommended when a continuous infusion of a relaxant is used.
对于全静脉麻醉(TIVA),麻醉方法所需的所有药物均通过静脉给药。这通常意味着使用静脉输注。静脉注射肌肉松弛剂是常规做法,尽管也使用过其他给药途径。使用肌肉松弛剂首先是为了确保肌肉麻痹,其次是维持肌肉麻痹状态。目前常规使用的所有非去极化神经肌肉阻滞剂的起效速度相似;正常临床剂量达到最大效果大约需要3 - 6分钟。维持足够的阻滞水平是必要的,并且阻滞水平相对恒定通常对外科医生有帮助。药物的选择很重要。它应引起可忽略不计的副作用。对于通过输注给药,具有中等(如阿曲库铵)或短(如米库氯铵)作用持续时间的药物对于确保输注终止后效应的快速恢复至关重要。当持续输注松弛剂时,建议常规使用神经肌肉监测。